This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Hodgkin's disease
  • /
  • Hodgkin's lymphoma: ESMO Clinical Practice Guideli...

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Read time: 1 mins
Last updated:1st Oct 2018

The 2018 ESMO Clinical Practice Guidelines on Hodgkin lymphoma (HL) are based on results from recent studies and analyses. New recommendations are given regarding treatment with BEACOPPescalated, brentuximab vedotin and anti-PD-1 antibodies. An updated recommendation for regular follow-up comprising screening examinations for malignant and non-malignant late sequelae is included, as therapy-related late effects are frequently observed in HL survivors.


Read full guideline